Cost savings and increased access with ultra-low-dose immunotherapy Editorial


Authors: Mitchell, A. P.; Goldstein, D. A.
Title: Cost savings and increased access with ultra-low-dose immunotherapy
Keywords: monoclonal antibody; cost control; antibodies, monoclonal; immunotherapy; cost-benefit analysis; cost benefit analysis; cost savings; humans; human
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 2
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-01-10
Start Page: 170
End Page: 172
Language: English
DOI: 10.1200/jco.22.01711
PUBMED: 36265102
PROVIDER: scopus
PMCID: PMC9839306
DOI/URL:
Notes: Editorial -- Export Date: 1 February 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors